Netherlands· NL-b2ae999aeb34
Miconazolnitraat/Hydrocortison Teva 20/10 mg/g, hydrofiele crème
A imidazole/triazole in kombination mit corticosteroiden product containing hydrocortison + miconazolnitraat, registered in Netherlands by Teva B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Imidazole/triazole in kombination mit corticosteroiden is registered in 11 of 19 countries.
Countries holding a registration under ATC D01AC20 (imidazole/triazole in kombination mit corticosteroiden), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Imidazole/triazole in kombination mit corticosteroiden · ATC D01AC20
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCORTISON + MICONAZOLNITRAAT
- Manufacturer
- Teva B.V.
- Country
- Netherlands (NL)
- ATC code
- D01AC20
- ATC class
- Imidazole/Triazole in Kombination mit Corticosteroiden
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id15469
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imidazole/triazole in kombination mit corticosteroiden in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDaktacort 2%/1% creamJanssen-Cilag Ltd
- United StatesCysndra Ringworm CreamGuangzhou Xinhongda Trading Service Co., Ltd.
- FinlandDaktacortMcNeil / JNTL Consumer Health (Finland) Oy
- IcelandDaktacortMcNeil Sweden AB
- SwedenCortimyk 20 mg/g + 10 mg/g KrämKaro Pharma AB
- NorwayCortimykKaro Pharma AB (1)
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Daktacort
- Bulgaria · Дактакорт
- Cyprus · Candiplas H, Daktodor
- Denmark · Brentacort
- Spain · Brentán
- Finland · Daktacort
- United Kingdom (Northern Ireland) · Daktacort Hydrocortisone
- Greece · Daktodor
- Iceland · Daktacort
- Luxembourg · Daktacort
- Malta · Candiplas H, Daktodor
- Norway · Cortimyk
- Portugal · Daktacort
- Sweden · Cortimyk, Daktacort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7801a0fd-1ca1-4373-9f19-c5450a8ba405 GET /v1/drugs/7801a0fd-1ca1-4373-9f19-c5450a8ba405?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Crème",
"route": "Cutaan gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h15469_smpc.pdf",
"strength": null,
"atc_label": "Imidazoles / triazoles in combination with corticosteroids",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg15469",
"excipients": [
"BENZOËZUUR (E 210)",
"ETHYLEENGLYCOLMONOPALMITOSTEARAAT",
"MACROGOLSTEARAAT, TYPE I",
"OLEOYL MACROGOLGLYCERIDES",
"PARAFFINE, VLOEIBAAR (E905)",
"WATER, GEZUIVERD"
],
"substances": [
"HYDROCORTISON",
"MICONAZOLNITRAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h15469.pdf",
"authorised_at": "1993/11/01",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "15469",
"additional_monitoring": "N"
}See everything about imidazole/triazole in kombination mit corticosteroiden.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.